rs750905383
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_005751.5(AKAP9):c.2113T>G(p.Leu705Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000994 in 1,609,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L705L) has been classified as Likely benign.
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Publications
- male infertility with azoospermia or oligozoospermia due to single gene mutationInheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center
- long QT syndrome 11Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151966Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000123 AC: 3AN: 243234 AF XY: 0.00000756 show subpopulations
GnomAD4 exome AF: 0.00000686 AC: 10AN: 1457038Hom.: 0 Cov.: 35 AF XY: 0.00000690 AC XY: 5AN XY: 724486 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151966Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74224 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Long QT syndrome 11 Uncertain:1
- -
AKAP9-related disorder Uncertain:1
The AKAP9 c.2113T>G variant is predicted to result in the amino acid substitution p.Leu705Val. This variant was reported in a cohort of individuals with long QT syndrome; however, detailed clinical information was not available (supplementary material, Mullally et al. 2013. PubMed ID: 23174487). This variant is reported in 0.0032% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-91631344-T-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Long QT syndrome Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 526965). This missense change has been observed in individual(s) with long QT syndrome (PMID: 23174487). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 705 of the AKAP9 protein (p.Leu705Val). -
Cardiovascular phenotype Uncertain:1
The p.L705V variant (also known as c.2113T>G), located in coding exon 8 of the AKAP9 gene, results from a T to G substitution at nucleotide position 2113. The leucine at codon 705 is replaced by valine, an amino acid with highly similar properties. This variant has been detected in a long QT syndrome cohort; however, clinical details were limited (Mullally J et al. Heart Rhythm, 2013 Mar;10:378-82). This amino acid position is well conserved in available vertebrate species; however, valine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at